SynGen Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 24

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $1M

SynGen General Information

Description

Developer of instrument systems designed to harvest stem and progenitor cells from umbilical cord blood, bone marrow, peripheral blood and cell culture. The company develops regenerative medicine and other emerging applications for high-value cells by providing researchers, clinicians and manufacturers with systems that improve the recovery, purity and viability of stem and other clinically important cells from umbilical cord blood, peripheral blood, bone marrow, and cell culture.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 6017 Snell Avenue Genprice
  • San Jose, CA 95123
  • United States
+1 (408)
Primary Industry
Other Devices and Supplies
Other Industries
Biotechnology
Medical Supplies
Vertical(s)
Corporate Office
  • 6017 Snell Avenue Genprice
  • San Jose, CA 95123
  • United States
+1 (408)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

SynGen Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Merger/Acquisition 07-Jul-2017 $1M Completed Generating Revenue
6. Later Stage VC 26-Jun-2017 Completed Generating Revenue
5. Later Stage VC 10-May-2016 Completed Generating Revenue
4. Early Stage VC 06-Oct-2014 Completed Startup
3. Debt - General 27-Feb-2014 Completed Startup
2. Early Stage VC (Series A) 09-Jul-2013 $1M $6M Completed Startup
1. Early Stage VC (Series A) 18-Apr-2012 $5M $5M Completed Startup
To view SynGen’s complete valuation and funding history, request access »

SynGen Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
To view SynGen’s complete cap table history, request access »

SynGen Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of instrument systems designed to harvest stem and progenitor cells from umbilical cord blood, bone marrow, pe
Other Devices and Supplies
San Jose, CA
24 As of 2016

Houston, TX
 

Folsom, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

SynGen Competitors (16)

One of SynGen’s 16 competitors is Synthecon, a Formerly Accelerator/Incubator backed company based in Houston, TX.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Synthecon Formerly Accelerator/Incubator backed Houston, TX
StemExpress Corporation Folsom, CA
StressMarq Biosciences Corporation Victoria, Canada
OriGen Biomedical Corporation Austin, TX
STEMCELL Technologies Private Debt Financed Vancouver, Canada
You’re viewing 5 of 16 competitors. Get the full list »

SynGen Patents

SynGen Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2017117349-A2 Cell separation devices, systems, and methods Inactive 29-Dec-2015
WO-2017117349-A3 Cell separation devices, systems, and methods Inactive 29-Dec-2015
JP-2018525193-A Method for preparing an osteogenic bone graft Active 31-Jul-2015
WO-2017023542-A1 Method of preparing an osteogenic bone graft Inactive 31-Jul-2015
WO-2016183018-A1 Cryogenic storage bag Inactive 12-May-2015 A61J1/10
To view SynGen’s complete patent history, request access »

SynGen Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

SynGen Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Bay City Capital Venture Capital Minority
To view SynGen’s complete investors history, request access »

SynGen FAQs

  • When was SynGen founded?

    SynGen was founded in 2009.

  • Where is SynGen headquartered?

    SynGen is headquartered in San Jose, CA.

  • What is the size of SynGen?

    SynGen has 24 total employees.

  • What industry is SynGen in?

    SynGen’s primary industry is Other Devices and Supplies.

  • Is SynGen a private or public company?

    SynGen is a Private company.

  • What is the current valuation of SynGen?

    The current valuation of SynGen is .

  • What is SynGen’s current revenue?

    The current revenue for SynGen is .

  • How much funding has SynGen raised over time?

    SynGen has raised $20.7M.

  • Who are SynGen’s investors?

    Bay City Capital has invested in SynGen.

  • Who are SynGen’s competitors?

    Synthecon, StemExpress, StressMarq Biosciences, OriGen Biomedical, and STEMCELL Technologies are some of the 16 competitors of SynGen.

  • When was SynGen acquired?

    SynGen was acquired on 07-Jul-2017.

  • Who acquired SynGen?

    SynGen was acquired by ThermoGenesis Holdings.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process